Usage of Dabigatran Versus Warfarin for Patients with Atrial Fibrillation

被引：0
|
作者：
Guthrie, Robert [1 ]
机构：
[1] Ohio State Univ, Columbus, OH 43212 USA
来源：
POSTGRADUATE MEDICINE | 2010年 / 122卷 / 04期
关键词：
D O I：
10.3810/pgm.2010.07.2193
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：230 / 231
页数：2
相关论文
共 50 条
  • [21] Dabigatran etexilate: An alternative to warfarin for patients with nonvalvular atrial fibrillation
    Scott, Katie A.
    Amirehsani, Karen A.
    [J]. JOURNAL OF THE AMERICAN ASSOCIATION OF NURSE PRACTITIONERS, 2015, 27 (04) : 190 - 196
  • [22] Comparative Effectiveness of Dabigatran and Rivaroxaban versus Warfarin in Patients With Non-Valvular Atrial Fibrillation
    Bengtson, Lindsay
    Chen, Lin
    MacLehose, Richard
    Lutsey, Pamela
    Alonso, Alvaro
    [J]. CIRCULATION, 2014, 130
  • [23] Safety of Dabigatran Versus Warfarin for Periprocedural Anticoagulation in Patients Undergoing Ablation for Atrial Fibrillation Reply
    Lakkireddy, Dhanunjaya
    Reddy, Yeruva Madhu
    Di Biase, Luigi
    Natale, Andrea
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (12) : 1119 - 1120
  • [24] Insights from the dabigatran versus warfarin in patients with atrial fibrillation (RE-LY) trial
    Khoo, Chee W.
    Lip, Gregory Y. H.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (04) : 685 - 687
  • [25] EFFECTIVENESS AND SAFETY OF APIXABAN, DABIGATRAN AND RIVAROXABAN VERSUS WARFARIN IN FRAIL PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION
    Coleman, Craig I.
    Turpie, Alexander
    Bunz, Thomas J.
    Sood, Nitesh
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 290 - 290
  • [26] Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Frail Patients With Nonvalvular Atrial Fibrillation
    Martinez, Brandon K.
    Sood, Nitesh A.
    Bunz, Thomas J.
    Coleman, Craig I.
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2018, 7 (08):
  • [27] Dabigatran versus Warfarin in Patients with Atrial Fibrillation. Results of the RE-LY study
    不详
    [J]. KARDIOLOGIYA, 2009, 49 (10) : 75 - 76
  • [28] Higher Persistence in Newly Diagnosed Nonvalvular Atrial Fibrillation Patients Treated With Dabigatran Versus Warfarin
    Zalesak, Martin
    Siu, Kimberly
    Francis, Kevin
    Yu, Chen
    Alvrtsyan, Hasmik
    Rao, Yajing
    Walker, David
    Sander, Stephen
    Miyasato, Gavin
    Matchar, David
    Sanchez, Herman
    [J]. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2013, 6 (05): : 567 - 574
  • [29] Dabigatran Dual Therapy Versus Warfarin Triple Therapy Post PCI in Patients With Atrial Fibrillation
    Steg, Philippe Gabriel
    Ducrocq, Gregory
    Bhatt, Deepak L.
    Hohnloser, Stefan H.
    Nordaby, Matias
    Miede, Corinna
    Lip, Gregory Y. H.
    Oldgren, Jonas
    Ten Berg, Jurrien M.
    Cannon, Christopher P.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (02) : 238 - 240
  • [30] COST-EFFECTIVENESS OF DABIGATRAN VERSUS WARFARIN IN ATRIAL FIBRILLATION MANAGEMENT IN COLOMBIA
    Alfonso-Cristancho, R.
    Herran, S.
    Caicedo, M.
    Gomez, E.
    [J]. VALUE IN HEALTH, 2011, 14 (07) : A536 - A537
12345